Evidence map›Paper›PMID 41942608›Full record

ArticleBritish journal of cancer2026

Performance of an image-only deep learning breast cancer risk model with the addition of a polygenic risk score.

Shadi Azam, Leslie R Lamb, A Heather Eliassen, Tari A King, Michelle Specht, Peter Kraft, Sara Lindstrom, Constance D Lehman, Rulla M Tamimi

Abstract read
In one paragraph

Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shadi Azam *Department of Population Health Sciences, Weill Cornell Medicine, New York, USA. sha4015@med.cornell.edu.ORCID http://orcid.org/0000-0002-3273-1970
Leslie R Lamb *Division of Breast Imaging, Department of Radiology, Mass General Brigham, Boston, USA.
A Heather EliassenDepartments of Nutrition and Epidemiology, Harvard T H Chan School of Public Health, Boston, USA.ORCID http://orcid.org/0000-0002-3961-6609
Tari A KingDepartment of Surgery, Emory Winship Cancer Institute, Atlanta, Georgia, USA.
Michelle SpechtDivision of Surgical Oncology, Mass General Brigham, Boston, USA.
Peter KraftTransdivisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Sara LindstromDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Constance D Lehman *Division of Breast Imaging, Department of Radiology, Mass General Brigham, Boston, USA.ORCID http://orcid.org/0000-0001-5839-6675
Rulla M Tamimi *Department of Population Health Sciences, Weill Cornell Medicine, New York, USA.ORCID http://orcid.org/0000-0003-2306-8668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMammograms contain imaging biomarkers that can predict future breast cancer risk using deep learning (DL) models. We evaluated whether adding a polygenic risk score (PRS) improves performance of the image-only DL breast cancer risk model Mirai.

methodsThis nested case-control study within the Nurses' Health Study 2 included 902 women (270 cases, 632 controls) who underwent bilateral 2D digital screening mammography between 2001-2017. Risk was assessed using Mirai and, for clinical comparison, the Gail 5-year model. A PRS was calculated using 313 breast cancer-associated single-nucleotide polymorphisms. The primary outcome was incident breast cancer within five years of the index mammogram. Discrimination was evaluated using area under the receiver operating characteristic curve (AUC), with comparisons using the DeLong test.

resultsMean age was 55.5 years(SD 5.3). Among cases, median time from index mammogram to diagnosis was 2.0 years (IQR0.5-4.0). Mirai alone achieved an AUC of 0.66 (95% CI: 0.62-0.70), increasing to 0.73 (95% CI 0.67-0.78; P = 0.05) with PRS. The Gail model improved from 0.52 (95% CI: 0.47-0.57) to 0.69 (95% CI: 0.62-0.76; P < 0.001) with PRS. Mirai+PRS significantly outperformed Gail+PRS (P < 0.001).

conclusionsIntegrating PRS with DL-based mammographic models modestly improves risk discrimination and may enhance personalized screening.

Indexed as

Breast NeoplasmsDeep LearningMammographyAgedCase-Control StudiesEarly Detection of CancerFemaleGenetic Predisposition to DiseaseGenetic Risk ScoreHumansMiddle AgedPolymorphism, Single NucleotideRisk AssessmentRisk FactorsROC Curve

Identifiers

PMID41942608
PMCPMC13183889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.